NASDAQ | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 8.14% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 7.41% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 7.21% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 6.12% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 5.67% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.13% |
| ALXN | Alexion Pharmaceuticals Inc | Healthcare | Biotechnology | 3.02% |
| SGEN | Seagen Inc | Healthcare | Biotechnology | 2.25% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 2.09% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.91% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.6% |
| MYL | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.35% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 1.29% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.16% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 1.15% |
| NVCR | Novocure Ltd | Healthcare | Medical Devices | 1.1% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 1.03% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.02% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 1.02% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 0.96% |
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.